294 related articles for article (PubMed ID: 33543775)
1. Migraine treatment and COVID-19 vaccines: No cause for concern.
Gelfand AA; Poland G
Headache; 2021 Mar; 61(3):409-411. PubMed ID: 33543775
[No Abstract] [Full Text] [Related]
2. COVID-19 vaccines for patients with haematological conditions.
Sun C; Pleyer C; Wiestner A
Lancet Haematol; 2021 May; 8(5):e312-e314. PubMed ID: 33811822
[No Abstract] [Full Text] [Related]
3. Doctor-Should I get the COVID-19 vaccine? Infection and immunization in individuals with neuromuscular disorders.
Živković SA; Gruener G; Narayanaswami P;
Muscle Nerve; 2021 Mar; 63(3):294-303. PubMed ID: 33471383
[TBL] [Abstract][Full Text] [Related]
4. The Century of mRNA Vaccines: COVID-19 Vaccines and Allergy.
Ortega Rodríguez NR; Audícana Berasategui MT; de la Hoz Caballer B; Valero Santiago A
J Investig Allergol Clin Immunol; 2021 Feb; 31(1):89-91. PubMed ID: 33393485
[No Abstract] [Full Text] [Related]
5. Talk of the town in 2021: Covid-19 vaccines likely take centre stage.
Höglund P
Scand J Immunol; 2021 Jan; 93(1):e13014. PubMed ID: 33372339
[No Abstract] [Full Text] [Related]
6. Equitable global access to coronavirus disease 2019 vaccines.
Schwartz JL
BMJ; 2020 Dec; 371():m4735. PubMed ID: 33323384
[No Abstract] [Full Text] [Related]
7. Cancer and COVID-19 vaccines: a complex global picture.
Yusuf A; Sarfati D; Booth CM; Pramesh CS; Lombe D; Aggarwal A; Bhoo-Pathy N; Tsunoda A; Vanderpuye V; Kutluk T; Sullivan A; Mukherji D; Mutebi M; van Hemelrijck M; Sullivan R;
Lancet Oncol; 2021 Jun; 22(6):749-751. PubMed ID: 33930324
[No Abstract] [Full Text] [Related]
8. COVID-19 vaccines: one step towards the beginning of the end of the global impact of the pandemic.
Cook TM; Farrar JJ
Anaesthesia; 2021 Apr; 76(4):435-443. PubMed ID: 33316853
[No Abstract] [Full Text] [Related]
9. SARS-CoV-2 and the rheumatology patient: the last 12 months and a boost in the future.
Winthrop KL; Whitley RJ; Aletaha D
Ann Rheum Dis; 2021 Oct; 80(10):1249-1251. PubMed ID: 34518198
[No Abstract] [Full Text] [Related]
10. COVAX Statement on WHO emergency use listing for AstraZeneca/Oxford COVID-19 vaccine.
Neurosciences (Riyadh); 2021 Apr; 26(2):222-223. PubMed ID: 33814381
[No Abstract] [Full Text] [Related]
11. A Reserve System for the Equitable Allocation of a Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine.
Makhoul AT; Drolet BC
Chest; 2021 Mar; 159(3):1292-1293. PubMed ID: 33453180
[No Abstract] [Full Text] [Related]
12. Evaluating SARS-CoV-2 Vaccines After Emergency Use Authorization or Licensing of Initial Candidate Vaccines.
Joffe S
JAMA; 2021 Jan; 325(3):221-222. PubMed ID: 33315069
[No Abstract] [Full Text] [Related]
13. Covid-19: US Catholics split after bishops' conference recommends against Johnson and Johnson vaccine.
Dyer O
BMJ; 2021 Mar; 372():n666. PubMed ID: 33687968
[No Abstract] [Full Text] [Related]
14. Messenger RNA vaccines against SARS-CoV-2.
Topol EJ
Cell; 2021 Mar; 184(6):1401. PubMed ID: 33740443
[TBL] [Abstract][Full Text] [Related]
15. Understanding the dynamics of COVID-19; implications for therapeutic intervention, vaccine development and movement control.
Salvamani S; Tan HZ; Thang WJ; Ter HC; Wan MS; Gunasekaran B; Rhodes A
Br J Biomed Sci; 2020 Oct; 77(4):168-184. PubMed ID: 32942955
[TBL] [Abstract][Full Text] [Related]
16. [Vaccination immunology in SARS-CoV-2].
Helweg-Larsen J; Benfield T
Ugeskr Laeger; 2021 Mar; 183(11):. PubMed ID: 33734074
[TBL] [Abstract][Full Text] [Related]
17. India begins COVID-19 vaccination amid trial allegations.
Bhuyan A
Lancet; 2021 Jan; 397(10271):264. PubMed ID: 33485435
[No Abstract] [Full Text] [Related]
18. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
[TBL] [Abstract][Full Text] [Related]
19. Vaccinating against covid-19 in people who report allergies.
Glover RE; Urquhart R; Lukawska J; Blumenthal KG
BMJ; 2021 Jan; 372():n120. PubMed ID: 33461962
[No Abstract] [Full Text] [Related]
20. Transforming vaccine development.
Black S; Bloom DE; Kaslow DC; Pecetta S; Rappuoli R
Semin Immunol; 2020 Aug; 50():101413. PubMed ID: 33127296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
